These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 27122979)

  • 1. A retrospective study on the role of diabetes and metformin in colorectal cancer disease survival.
    Ramjeesingh R; Orr C; Bricks CS; Hopman WM; Hammad N
    Curr Oncol; 2016 Apr; 23(2):e116-22. PubMed ID: 27122979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective analysis of the role of proton pump inhibitors in colorectal cancer disease survival.
    Graham C; Orr C; Bricks CS; Hopman WM; Hammad N; Ramjeesingh R
    Curr Oncol; 2016 Dec; 23(6):e583-e588. PubMed ID: 28050148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin Increases Overall Survival in Patients with Diabetes Undergoing Surgery for Colorectal Cancer.
    Fransgaard T; Thygesen LC; Gögenur I
    Ann Surg Oncol; 2016 May; 23(5):1569-75. PubMed ID: 26714936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Use of Metformin and Postoperative Insulin Pump Were Predictive Factors for Outcomes of Diabetic Colorectal Cancer Patients after Surgery.
    Liu XR; Liu F; Li ZW; Lv Q; Shu XP; Li LS; Tong Y; Zhang W; Peng D
    Nutr Cancer; 2023; 75(10):1926-1933. PubMed ID: 37870939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus.
    Lee JH; Kim TI; Jeon SM; Hong SP; Cheon JH; Kim WH
    Int J Cancer; 2012 Aug; 131(3):752-9. PubMed ID: 21913184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pathological characteristics and prognostic analysis of 1,013 breast cancer patients with diabetes.
    Hou G; Zhang S; Zhang X; Wang P; Hao X; Zhang J
    Breast Cancer Res Treat; 2013 Feb; 137(3):807-16. PubMed ID: 23292119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of diabetes and metformin on clinical outcomes is negligible in risk-adjusted endometrial cancer cohorts.
    Al Hilli MM; Bakkum-Gamez JN; Mariani A; Cliby WA; Mc Gree ME; Weaver AL; Dowdy SC; Podratz KC
    Gynecol Oncol; 2016 Feb; 140(2):270-6. PubMed ID: 26607780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival benefits of metformin for colorectal cancer patients with diabetes: a systematic review and meta-analysis.
    Mei ZB; Zhang ZJ; Liu CY; Liu Y; Cui A; Liang ZL; Wang GH; Cui L
    PLoS One; 2014; 9(3):e91818. PubMed ID: 24647047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can metformin improve 'the tomorrow' of patients treated for oesophageal cancer?
    Van De Voorde L; Janssen L; Larue R; Houben R; Buijsen J; Sosef M; Vanneste B; Schraepen MC; Berbée M; Lambin P
    Eur J Surg Oncol; 2015 Oct; 41(10):1333-9. PubMed ID: 26091848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of diabetes mellitus and metformin use on oncologic outcomes of patients treated with radical cystectomy for urothelial carcinoma.
    Rieken M; Xylinas E; Kluth L; Crivelli JJ; Chrystal J; Faison T; Lotan Y; Karakiewicz PI; Sun M; Fajkovic H; Babjuk M; Bachmann A; Scherr DS; Shariat SF
    Urol Oncol; 2014 Jan; 32(1):49.e7-14. PubMed ID: 24140245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of metformin on cancer-specific survival outcomes in diabetic patients undergoing radical cystectomy for urothelial carcinoma of the bladder.
    Nayan M; Bhindi B; Yu JL; Hermanns T; Mohammed A; Hamilton RJ; Finelli A; Jewett MA; Zlotta AR; Fleshner NE; Kulkarni GS
    Urol Oncol; 2015 Sep; 33(9):386.e7-13. PubMed ID: 26097049
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin increases survival in hormone receptor-positive, HER2-positive breast cancer patients with diabetes.
    Kim HJ; Kwon H; Lee JW; Kim HJ; Lee SB; Park HS; Sohn G; Lee Y; Koh BS; Yu JH; Son BH; Ahn SH
    Breast Cancer Res; 2015 May; 17(1):64. PubMed ID: 25935404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin for primary colorectal cancer prevention in patients with diabetes: a case-control study in a US population.
    Sehdev A; Shih YC; Vekhter B; Bissonnette MB; Olopade OI; Polite BN
    Cancer; 2015 Apr; 121(7):1071-8. PubMed ID: 25424411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes mellitus without metformin intake is associated with worse oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
    Rieken M; Xylinas E; Kluth L; Trinh QD; Lee RK; Fajkovic H; Novara G; Margulis V; Lotan Y; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Karakiewicz PI; Scherr DS; Briganti A; Kautzky-Willer A; Bachmann A; Shariat SF;
    Eur J Surg Oncol; 2014 Jan; 40(1):113-20. PubMed ID: 24113620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A cohort study of metformin exposure and survival in patients with stage I-III colorectal cancer.
    Spillane S; Bennett K; Sharp L; Barron TI
    Cancer Epidemiol Biomarkers Prev; 2013 Aug; 22(8):1364-73. PubMed ID: 23753040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Metabolic Syndrome Diagnosis and Its Treatment on Survival of Colorectal Cancer Patients.
    Mafiana RN; Al-Kindi MS; Mafiana N; Al Lawati AS; Al Moundhri M
    J Cancer Epidemiol; 2019; 2019():6527457. PubMed ID: 31139216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin and aspirin treatment could lead to an improved survival rate for Type 2 diabetic patients with stage II and III colorectal adenocarcinoma relative to non-diabetic patients.
    De Monte A; Brunetti D; Cattin L; Lavanda F; Naibo E; Malagoli M; Stanta G; Bonin S
    Mol Clin Oncol; 2018 Mar; 8(3):504-512. PubMed ID: 29456855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced colorectal cancer incidence in type 2 diabetic patients treated with metformin: a meta-analysis.
    Nie Z; Zhu H; Gu M
    Pharm Biol; 2016 Nov; 54(11):2636-2642. PubMed ID: 27159666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin use and survival after colorectal cancer: A population-based cohort study.
    Mc Menamin ÚC; Murray LJ; Hughes CM; Cardwell CR
    Int J Cancer; 2016 Jan; 138(2):369-79. PubMed ID: 26331456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smad4 inactivation predicts for worse prognosis and response to fluorouracil-based treatment in colorectal cancer.
    Kozak MM; von Eyben R; Pai J; Vossler SR; Limaye M; Jayachandran P; Anderson EM; Shaffer JL; Longacre T; Pai RK; Koong AC; Chang DT
    J Clin Pathol; 2015 May; 68(5):341-5. PubMed ID: 25681512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.